Literature DB >> 12722773

Current trends and controversies in ischemia-reperfusion research--meeting report of the Hatter Institute 3rd International Workshop on Cardioprotection.

Gary F Baxter1, Derek M Yellon.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12722773     DOI： 10.1007/s00395-003-0393-z

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN： 0300-8428            Impact factor:   17.165


× No keyword cloud information.
  5 in total

1.  Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.

Authors:  Fadi N Salloum; Yuko Takenoshita; Ramzi A Ockaili; Vladimir P Daoud; Eric Chou; Kazu-ichi Yoshida; Rakesh C Kukreja
Journal:  J Mol Cell Cardiol       Date:  2006-12-08       Impact factor: 5.000

Review 2.  Protective ischaemia in patients: preconditioning and postconditioning.

Authors:  Asger Granfeldt; David J Lefer; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

3.  S-nitrosylation of TRIM72 mends the broken heart: a molecular modifier-mediated cardioprotection.

Authors:  C Y X'avia Chan; Ding Wang; Martin Cadeiras; Mario C Deng; Peipei Ping
Journal:  J Mol Cell Cardiol       Date:  2014-04-13       Impact factor: 5.000

4.  Ischemic Postconditioning (IPostC) Protects Fibrotic and Cirrhotic Rat Livers after Warm Ischemia.

Authors:  Julia Schewe; Marie-Christine Makeschin; Ingrid Liss; Doris Mayr; Jiang Zhang; Andrej Khandoga; Simon Rothenfußer; Max Schnurr; Alexander L Gerbes; Christian J Steib
Journal:  Can J Gastroenterol Hepatol       Date:  2019-06-09

Review 5.  Determination of significant parameters in remote ischemic postconditioning for ischemic stroke in experimental models: A systematic review and meta-analysis study.

Authors:  Kezhou Liu; Zhengting Cai; Quanwei Zhang; Jiatong He; Yinuo Cheng; Shaonong Wei; Mengjie Yin
Journal:  CNS Neurosci Ther       Date:  2022-07-27       Impact factor: 7.035
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.